Evolution of pain and functional scores
| T0 | T1 | T2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Etanercept (n = 10) | Methyl-prednisolone (n = 10) | p | Etanercept (n = 10) | Methyl-prednisolone (n = 10) | p | Etanercept (n = 10) | Methyl-prednisolone (n = 10) | p | |||
| Results are given as mean (SD). | |||||||||||
| T0, inclusion; T1, day 10; T2, week 6; SD, standard deviation; VAS, visual analogue scale; VASL, VAS leg pain; VASB, VAS back pain; ODI, Oswestry Disability Index; RMDQ, Roland Morris Disease Questionnaire. | |||||||||||
| VASL 0–100 | 74.4 (12.9) | 75.1 (14.2) | NS | 20.2 (16.6) | 25.5 (15.5) | NS | 12.4 (13.2) | 52.9 (25.1) | <0.001 | ||
| VASB 0–100 | 36.4 (39.8) | 39.8 (29.2) | NS | 8.4 (11.9) | 19.9 (18.4) | NS | 7.4 (10.8) | 47.6 (28.5) | 0.002 | ||
| ODI 0–100 | 75.4 (19.4) | 62.4 (11.7) | NS | 33.9 (25.4) | 31.6 (15.3) | NS | 17.3 (13.1) | 33.4 (13.0) | <0.05 | ||
| RMDQ 0–24 | 17.8 (3.3) | 15.5 (2.9) | NS | 9.8 (7.8) | 10.4 (4.6) | NS | 5.8 (5.5) | 11.1 (4.6) | 0.1 | ||